An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)
Clinical trial NCT04987242 · COMPLETED
Trial details
- NCT number
- NCT04987242
- Sponsor
- Allena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-16
- Primary completion
- 2022-03-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.